Drug intelligence / Profile preview

polihexanide (Wuhan Shufuning Pharmaceutical)

Development stage
Preclinical
Lead developer
Wuhan Sufu'ning Pharmaceutical
Modality
Small Molecules
Administration
Intravesical
01

Overview

Su Fu'ning Lotion (SFN) is a proprietary formulation of **polihexanide** (polyhexamethylene biguanide; PHMB), a cationic polymer traditionally used as an antiseptic and disinfectant, which has been investigated as a novel intravesical perfusate for the treatment of bladder cancer. Developed primarily in China, SFN is intended for use as an adjuvant therapy following surgical resection (such as TURBT) to eliminate residual malignant cells and reduce the high rate of tumor recurrence. PHMB exerts its antineoplastic effects by disrupting cell membranes, binding to DNA, and inducing apoptosis in bladder cancer cells. Preclinical studies have demonstrated that SFN significantly inhibits the proliferation of bladder cancer cell lines (e.g., T24, BTT, BIU-87) and prolongs survival in animal models, showing efficacy comparable or superior to conventional chemotherapeutic agents like mitomycin C and pirarubicin.

Brand names
Su Fu'ning LotionSu Fu'ningSufuning
Other names
polyhexamethylene biguanidePHMBpolyhexanide
02

Targets

DNA

Beyond the preview

Go deeper on polihexanide (Wuhan Shufuning Pharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polihexanide (Wuhan Shufuning Pharmaceutical).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call